Introduction
Myxomatous heart valves are characterized by thickening of leaflets leading to abnormal leaflet displacement, incomplete closure of the valve, and ultimately regurgitation. The mitral valve is the most affected heart valve and myxomatous valve disease is the most common aetiology of primary mitral regurgitation. 1 Late stage human myxomatous diseased valves exhibit increased accumulation of glycosaminoglycans (GAG) accompanied by disorganization of collagen fibres, 2 increased cellularity 3 and induction of TGF-b and BMP signalling. 2, 3 Chondrogenic regulatory pathways, including expression of the transcription factor Sox9 and aggrecan, 3, 4 also are increased supporting the idea that MVD mimics aspects of chondrogenesis. 5 In addition, infiltration of inflammatory cells has been reported but their contribution to MVD is unknown. 2 Nevertheless, molecular pathways and cellular origins involved in the onset and progression of MVD are incompletely understood. Therefore, therapeutic targets are not yet available and surgery is still the only treatment.
Recent genetic studies indicate that congenital heart valve defects leading to defective leaflet remodelling precede MVD diagnosed much later in life [6] [7] [8] [9] when heart valve insufficiency occurs. Before birth, heart valve development starts with endothelial-mesenchymal transformation (EMT) of the endocardium to form mesenchymal cushions. During late gestation and after birth, the GAG-rich endocardial cushions undergo ECM remodelling and transform into stratified leaflets. 10 Along with ECM stratification and compaction, cell proliferation decreases during heart valve maturation. 10 Still, molecular pathways regulating heart valve maturation are far from being elucidated but are of critical importance, as defects in ECM organization and remodelling are common features of adult valve disease. Axin2 is a downstream target of Wnt/b-catenin signalling and also is an inhibitor of the pathway as part of a protein complex promoting bcatenin degradation. 11 In the developing skeleton, loss of Axin2 accelerates chondrocyte maturation by increasing Wnt/b-catenin signalling. 12 Before birth, Wnt/b-catenin signalling is active in VICs 13 and contributes to valve remodelling and proliferation in endocardial cushions. 14 Interestingly, b-catenin is required for adult heart valve homeostasis 4 and Wnt/b-catenin signalling is activated in human MVD. 15 However, the requirements for Axin2/Wnt/b-catenin signalling in postnatal valve remodelling or progression of MVD have not been determined previously.
Using Axin2 knockout (KO) mice (Axin2
LacZ/LacZ ), we investigated the role of Axin2/Wnt/b-catenin signalling in postnatal heart valve morphogenesis and adult disease progression. Axin2 is expressed throughout the valve leaflets and inhibits Wnt/b-catenin signalling and cell proliferation after birth. Axin2-deficiency leads to decreased fibrillar collagen deposition and Sox9 expression with progressive development of myxomatous features and aortic insufficiency in adult mice over the course of 4 months. Thus, Axin2 limits Wnt/b-catenin signalling in postnatal heart valve maturation, and loss of Axin2 contributes to MVD progression in adulthood.
Methods
Detailed Materials and Methods can be found in the Supplemental Material online.
Mice
All mouse experiments conform to NIH guidelines (Guide for the care and use of laboratory animals) and were performed with protocols approved by the Institutional Animal Care and Use Committee at Cincinnati Children's Research Foundation. Axin2
LacZ/þ mice, Fbn1 C1039G/þ mice and TCF/Lef:H2B-GFP transgenic mice were previously described. 11, 16, 17 To obtain littermate cohorts of Axin2 mice or Fbn1 C1039G/þ mice with TCF/Lef: H2B-GFP reporter, TCF/Lef:H2B-GFP mice were crossed with Axin2 LacZ/þ mice or Fbn1 C1039G/þ mice. Mice were sacrificed under isoflurane inhalation followed by cervical dislocation at the specified time point for each experiment. Male and female mice were used together for all analyses. Mice were maintained in mixed B6.129 strain background. Embryonic litters were collected at E14.5, with E0.5 determined by evidence of a vaginal plug.
Mouse echocardiography
Two-dimensional, M-mode and Doppler transthoracic echocardiography was performed on 2-month-old mice under anesthesia induced with inhaled isoflurane 0.8-1.5%. At least 12 mice per genotype were analysed.
Histology, morphometric analysis and immunofluorescence labelling
Murine tissues were harvested from foetal, neonatal, juvenile and adult mice at indicated time-points and processed for either paraffin embedding or cryo-preservation. Standard protocols were used for staining and immunohistochemistry. The integrity of collagen network was determined with picrosirius red polarization microscopy to quantify the ratio between thick closely packed mature collagen fibres as orange-red birefringence and the loosely packed less cross-linked and immature collagen fibres as yellowgreen birefringence. 18 Morphometric and immunofluorescence analyses were performed at the thickest part of aortic valve leaflet or mitral valve leaflet.
RNA isolation and real-time quantitative PCR (qPCR)
Aortic valve tissues were extracted using NucleoSpin RNA/Protein extraction kit (Macherey-Nagel) following manufacturer's instructions. Primer sequences are listed in Table S1 , see Supplementary material online.
Statistics
Mann-Whitney U tests were used to determine the significance of observed differences between the medians using PRISM6 software package (GraphPad). Data are reported as dot plots and interquartile ranges, where each dot represents a single mouse or biological sample and the horizontal bar indicates the median. A P value < 0.05 was considered significant.
Results

Axin2 is expressed in heart valves and loss of Axin2 results in delayed heart valve maturation
To evaluate the expression and function of Axin2 in heart valves, we used Axin2 LacZ/þ reporter mice in which b-galactosidase expression is under the control of the endogenous Axin2 locus while abolishing Axin2 gene transcription. 11 X-gal staining reveals that Axin2LacZ is expressed in aortic valve (AoV) (see Supplementary material online, Figure S1A ) and mitral valve (MV) (see Supplementary material online, Figure S1B ) leaflets after birth at postnatal day 0 (P0). Axin2LacZ is detected in valve endothelial cells (VECs) on the fibrosa side, whereas its expression is not observed in VECs on the ventricularis side exposed to blood flow (see Supplementary material online, Figure S1A To investigate the role of Axin2 in heart valve development and postnatal remodelling, we analysed the homozygous Axin2
LacZ/LacZ knockout mutants (KO). 19 At E14.5, Axin2LacZ is expressed in AoV leaflets, as confirmed by X-gal staining in Axin2 LacZ/þ reporter mice (see Supplementary material online, Figure S1C and C 0 ), but loss of Axin2 does not significantly alter the overall ECM composition and morphology of AoV (see Supplementary material online, Figure S1D -F). However, at P0, AoV leaflets are enlarged and composed predominantly of GAGs, as indicated by alcian blue staining ( Figure 1B vs. 1A) . Morphometric analysis confirms that AoV leaflet area is increased at P0 in Axin2 KO mice ( Figure 1C) . Mitral valves are also affected with increased anterior and posterior leaflets area at P0 ( Figure 1D ). The proteoglycan versican is expressed throughout Axin2 KO AoV leaflet ( Figure 1F ) as opposed to versican expression specifically in the tip of WT AoV leaflets ( Figure 1E ), consistent with alcian blue staining. Axin2 KO AoV, exhibit decreased collagen staining in the tip and hinge of AoV leaflets (empty arrowheads in Figure  1H ) along with reduction of col1a1 and col3a1 mRNA expression ( Figure   Loss Figure 1G) . Moreover, elastin (eln), normally induced during late embryonic and postnatal remodelling, is significantly decreased in Axin2 KO AoV ( Figure 1I ). Finally, a cross section of AoV shows that the three AoV cusps are thickened in Axin2 KO mice ( Figure  1J and K). Thus, loss of Axin2 leads to abnormal postnatal ECM remodelling evident in increased proteoglycan expression and decreased fibrillar collagen and elastin expression. During normal postnatal heart valve remodelling, VIC proliferation decreases. 10 To determine if Axin2 KO VICs go through normal postnatal cell cycle arrest, we assessed cell proliferation with pHH3 immunofluorescence ( Figure 1L and M). The percent of pHH3-positive cells was determined at P0 and increased cell proliferation was detected in Axin2 KO AoV ( Figure 1N ). In Axin2 KO AoV, the total number of cells is increased at P0 ( Figure 1O ), however, cell numbers were not significantly altered in E14.5 Axin2 KO AoV (see Supplementary material online, Figure S1G ). Like Axin2 expression, the majority of pHH3-positive cells are found in the distal part of Axin2 KO AoV leaflets. Therefore, loss of Axin2 leads to increased VIC proliferation after birth.
1I) relative to WT controls (
Wnt/b-catenin signalling is increased in Axin2 KO AoV mesenchyme while Sox9 expression is decreased
To test whether the absence of Axin2 stimulates Wnt/b-catenin signalling in AoV, we generated Axin2 KO that carry one copy of TCF/Lef:H2B-GFP, a transgenic reporter of canonical Wnt/b-catenin signalling mediated by TCF/LEF transcriptional activity. 16 At P0, Wnt/b-catenin signalling, indicated by GFP staining, is detectable in many WT AoV VECs localized to the fibrosa side, but only in a few VICs ( Figure 2A ). However, TCF/Lef:H2B-GFP expression is markedly activated in VICs when Axin2 is absent ( Figure 2B ). Interestingly, Wnt/b-catenin signalling is mostly activated at the tip of the leaflet ( Figure 2B ), which overlaps with Axin2 expression (see Supplementary material online, Figure S1A ). Quantification of GFP-positive cells in Axin2 KO AoV confirms the increased Wnt/b-catenin signalling ( Figure 2C ). Expression of Sox9, a transcription factor essential for ECM maturation during heart valve development and antagonized by Wnt/b-catenin signalling during chondrogenesis, was measured. 7, 20, 21 In WT, nuclear Sox9 is widely expressed throughout valve leaflets ( Figure 2D ). Strikingly, Sox9 is decreased in Axin2 KO mice ( Figure 2E and F), and the majority of cells with Wnt/b-catenin signalling in Axin2 KO AoV do not express Sox9 ( Figure 2H ). Finally, Sox9 mRNA expression is significantly decreased in Axin2 KO AoV ( Figure 2I ). Thus, loss of Axin2 leads to increased Wnt/b-catenin signalling and reduced Sox9 expression during heart valve maturation after birth.
Adult Axin2 KO mice display AoV thickening and insufficiency
The consequences of loss of Axin2 on adult heart valve structure and function were examined in 2-month-old Axin2 KO mice compared to WT. In contrast to P0, Wnt/b-catenin signalling, indicated by TCF/Lef:H2B-GFP (see Supplementary material online, Figure S2A and B), is not changed in 2-month-old adult Axin2 KO mice (see Supplementary material online, Figure  S2C ). However, adult Axin2 KO mice display thickened AoV (see Supplementary material online, Figures S2B vs. S2A and 3C) with enlargement of the three AoV cusps ( Figure 3B vs. 3A and see Supplementary material online, Figure S6B ) and increased cell numbers ( Figure 3D) . As revealed by pentachrome staining (yellow stain in Figure S2E , see Supplementary material online) and collagen type III immunofluorescence (see Supplementary material online, Figure S2G ), collagen is expressed in the tip of Axin2 KO AoV whereas collagen is barely detected in the tip of Axin2 WT AoV (see Supplementary material online, Figure S2D and empty arrowhead in Figure S2F ). Similarly, versican is expressed and accumulates in Axin2 KO AoV (see Supplementary material online, Figure S2I vs. S2H). Therefore, lack of Axin2 gives rise to immature AoV that remain thickened with disorganized ECM into adulthood. Thickening of heart valves may impair their function, as MVD leads to heart valve insufficiency. Therefore, left side heart valve function was assessed by echocardiography. Pulsed wave Doppler across AoV indicates heterogeneity of dysfunction in Axin2 KO mice. Indeed, 4/12 of 2-month-old Axin2 KO mice display retrograde diastolic flow across the AoV (arrowhead in Figure 3G ), whereas the other Axin2 KO mice show a pulsed wave Doppler ( Figure 3F ) similar to Axin2 WT mice ( Figure 3E) . The abnormal pulsed wave Doppler is typical of aortic insufficiency (AI), which is detected by colour Doppler during diastole ( Figure 3I vs. 3H) . Based on colour Doppler, Axin2 KO mice were divided in two groups (Axin2 KO with and Axin2 KO without AI) and peak transvalvular velocities were compared. The 4 Axin2 KO mice with AI had both significantly higher peak velocities ( Figure 3J ) and colour Doppler signal aliasing of antegrade aortic flow ( Figure 3I ). By comparison, Axin2 KO mice without AI had peak velocities indistinguishable from WT mice, and neither of these latter two groups had aliasing of the antegrade colour Doppler signal. Two of the four Axin2 KO mice with AI also demonstrated doming of the aortic valve leaflets, a finding not present in Axin2 KO mice without AI nor in any WT mice. Aortic valve leaflet prolapse was not observed in any of the animals and no difference was found in aortic dimensions (see Supplementary material online, Figure S3A-D) . Although histology demonstrated thickened mitral valves, no mitral valve insufficiency, prolapse, abnormal leaflet excursion or flow abnormalities (see Supplementary material online, Figure S3F -H) were observed in Axin2 KO mice. Altogether, these results indicate that loss of Axin2 leads to thickened AoV in adult mice with AoV regurgitation in a subset of animals.
Axin2 KO AoV exhibit progressive myxomatous valve disease
The progression of MVD was examined in older Axin2 KO mice at 4 months. At 4 months, the ECM abnormalities are even more striking than in 2-month-old Axin2 KO AoV ( Figure 4K vs. Figure S2E , see Supplementary material online). Similar to 2-month-old Axin2 KO mice, versican is expressed throughout the tip ( Figure 4B) . Likewise, collagen type III is extensively expressed in the tip ( Figure 4D and K) and overlaps with versican expression ( Figure 4B ). This indicates ECM disorganization compared to defined layers in WT mice ( Figure 4A and C) . Therefore, collagen fibre maturity was assessed by picrosirius red staining of AoV analysed under polarized light ( Figure 4E and F) . The ratio of orange-red (OR) birefringence, indicative of tightly packed and organized collagen fibres, relative to yellow-green (YG) loosely packed and less cross-linked collagen fibres (4G) indicates that the collagen network in Axin2 KO AoV is disorganized ( Figure 4F 0 ). Along with the extensive ECM remodelling at 4 months, expression of aggrecan is detected in the remodelled area of Axin2 KO leaflets ( Figure 4I ), while its presence is barely detectable in Axin2 WT ( Figure 4H phosphorylation of smad2/3 was used as an indicator of TGF-b signalling, and phosphorylation of smad1/5/8 was used to assess BMP signalling in the pathogenesis of myxomatous Axin2 KO AoV. Interestingly, while neither phosphorylation of smad2/3 (see Supplementary material online, Figure S4C ) nor smad1/5/8 (see Supplementary material online, Figure  S4E ) is altered in 2-month-old Axin2 KO mice, both display increased phosphorylation in 4-month-old Axin2 KO mice. Indeed, nuclear phosphorylation of smad2/3 is significantly increased in the VICs of Axin2 KO AoV ( Figure 5B and C), but is limited to VECs in WT AoV ( Figure 5A) . Similarly, p-smad1/5 immunoreactivity is significantly increased in thickened AoV ( Figure 5E and F) , while only few cells display p-smad1/5
in WT ( Figure 5D ). Gene expression of TGF-b family ligands (TGF-b1, TGF-b2, BMP2, BMP4) as well as BMP and TGF-b inhibitors (smad6 and smad7, respectively) along with periostin (postn), is not significantly altered in 2-month-old AoV, with the exception of decreased BMP4 expression ( Figure 5G) . Interestingly, while ligand mRNA expression is unchanged, smad6 is significantly decreased and postn increased in 4-month-old Axin2 KO AoV ( Figure 5G) , indicative of potential activation of BMP signalling in 4-month-old Axin2 KO mice. Therefore, loss of Axin2 ultimately leads to increased TGF-b and BMP signalling in myxomatous valves with severe ECM abnormalities at 4 months. Increased Wnt/b-catenin signalling has been associated with AoV calcification. 5 Thus, AoV calcification was evaluated in 1-year-old Axin2 KO mice by alizarin red staining. Calcification (see Supplementary material online, Figure S5C ) is not detected in Axin2 KO or WT mice (see Supplementary material online, Figure S5B vs. S5A) at 1 year. It was noted that black deposits (see Supplementary material online, Figure S6B ) accumulate in Axin2 KO AoV with progression of disease (see Supplementary material online, Figure S6B vs. S6A). The black cells are evident in unstained specimens and thus are not calcification. Prussian blue staining was used to test the possibility that these black deposits might be hemosiderin-laden macrophages. However, the absence of blue staining reveals that these accumulations are not iron (see Supplementary material online, Figure S6C -E). The black deposits are most likely melanin, as melanocytes populate heart valves, 22 and mitf and dct melanocytic markers are significantly increased in 2-month-old Axin2 KO AoV (see Supplementary material online, Figure S6F ). Therefore, Axin2 KO mice exhibit features of progressive MVD, but do not become calcified over time.
Axin2 KO mice exhibit increased inflammatory cells in AoV
Hematopoietic (CD45þ) cells have been described in normal heart valves 23 while increased inflammation has been reported in MVD. 2, 24 In normal WT AoV, the majority of CD45þ cells are localized under the endothelium at P0 ( Figure 6A ) and 4 months ( Figure  6D ). In contrast, in Axin2 KO AoV, CD45þ cells are increased and they are localized not only under the endothelium but also in the interstitium at P0 (Figure 6B and G) . Loss of Axin2 is systemic and Figure 6C ). Over time, CD45þ cells accumulate at the tip of AoV leaflet and at the commissure of AoV leaflet ( Figure 6E ) and progressively increase inside Axin2 KO AoV leaflets from P0 to 4 months ( Figure 6G) . Similarly macrophages, stained with Mac3, are present in higher numbers inside Axin2 KO AoV leaflets at 2 and 4 months ( Figure 6F and H) . Likewise, expression of chemokines CCL3 and CCL7 is increased at 2 months during early stages of pathogenesis ( Figure 6I ), indicating increased inflammation in Axin2 KO AoV prior to extensive myxomatous changes. Thus, loss of Axin2 leads to increased infiltration of inflammatory cells in AoV, preceding and potentially contributing to progression of MVD.
Axin2 expression is decreased and Wnt/b-catenin signalling is increased in myxomatous mitral valves of a murine model of Marfan syndrome
To determine if Axin2 expression is altered in an established model of myxomatous valve disease, we measured its expression in a murine model of Marfan syndrome. 25 These mice, carrying a mutation in Fbn1 (C1039G), recapitulate pathogenesis of Marfan syndrome, and display thickened mitral valves by 1 week after birth with increased cell proliferation. 25 Adult mice develop myxomatous mitral valves with mitral regurgitation detected at 9 months. (Figure 7E and F) . Thus, Wnt/b-catenin signalling is activated with myxomatous valve disease in a mouse model of Marfan syndrome.
Discussion
Here we show that Axin2 is required to limit activation of Wnt/b-catenin signalling after birth and that loss of Axin2 leads to progressive myxomatous ECM and signalling changes in adults, typical of human The number of p-smad1/5-positive cells/total nuclei was quantified in AoV leaflets (WT n = 6 and KO n = 6). Data are reported as dot plots and interquartile ranges, where each dot represents a mouse and the horizontal bar indicates the median. (G) TGF-b1, TGF-b2, BMP2, BMP4, smad6, smad7 and periostin (postn) expression were measured by qPCR in 2-month-old (WT n = 7, KO n = 7) and 4-month-old (WT n = 6, KO n = 5) Axin2 KO AoV, normalized to B2M and compared to Axin2 WT (set as 1, dotted line). Data are represented as box and whiskers. *P < 0.05 determined with Mann-Whitney U test. Scale bar =100 lm.
Loss of Axin2 promotes myxomatous valve disease
myxomatous valve disease. At P0, Axin2 KO AoV exhibit thickening, increased cell proliferation, and loss of ECM maturation. At 2 months, structural changes are apparent by histopathology, and a subset of Axin2 KO develops aortic insufficiency. Finally, postnatal heart valve defects in Axin2 KO mice lead ultimately to extensive ECM remodelling, chondrogenic protein expression, and activation of BMP signalling, hallmarks of myxomatous disease, apparent at 4 months. Interestingly, increased inflammatory cell infiltration and aortic insufficiency precede myxomatous changes in Axin2 KO mice, highlighting their potential contribution to ECM remodelling in MVD. Moreover, Axin2 KO AoV do not demonstrate calcification up to 1 year of age, although Wnt/b-catenin signalling is increased after birth. Altogether, our study shows that Axin2 and inhibition of Wnt/b-catenin signalling are required for proper heart valve maturation after birth and proposes the Axin2 KO mouse as a novel murine model of myxomatous valve disease. The total number of CD45þ cells in AoV leaflets was counted at P0 (WT n = 7 and KO n = 6), 2 months (WT n = 6 and KO n = 6) and 4 months (WT n = 7 and KO n = 7). (H) The total number of Mac3þ cells in AoV leaflets was counted at 2 months (WT n = 6 and KO n = 6) and 4 months (WT n = 6 and KO n = 6). (I) CCL2, CCL3 and CCL7 chemokine expression was measured by qPCR in 2-month-old Axin2 KO AoV, normalized to B2M and compared to Axin2 WT (WT n = 9 and KO n = 9). Data are reported as dot plots and interquartile ranges, where each dot represents a mouse (G and H) or biological sample (I) and the horizontal bar indicates the median. *P < 0.05 determined with Mann-Whitney U test. Scale bar =100 lm. Yellow scale bar =10 lm.
Axin2 limits Wnt/b-catenin signalling and promotes Sox9 expression in VICs postnatally
Increased Wnt/b-catenin signalling is apparent in Axin2 KO VICs at P0, as indicated by a TCF/LEF reporter. Although Wnt/b catenin signalling is crucial for EMT during cushion formation at the initiation of valve development, 26 Axin2 is not required for that process as indicated by similar interstitial cellularity evident at E14.5 in AoV, reported here, and in E13. 5 nin deletion leads to increased Sox9 nuclear localization in adult heart valves. 4 Thus, Axin2 limits Wnt/b-catenin signalling after birth, thereby maintaining Sox9 expression levels during heart valve maturation.
Axin2-deficiency leads to defective heart valve maturation
Signalling pathways involved in the transition from immature proliferative GAG-rich endocardial cushions to mature quiescent thin stratified valve leaflets are still largely unknown. Here, we demonstrate that loss of Axin2 maintains heart valves in an immature state after birth with increased cell proliferation, reduced collagen and elastin expression, and failure of ECM compaction. Our data revealing strong activation of Wnt/ b-catenin signalling in VICs upon loss of Axin2, combined with recent study demonstrating that Wnt/b-catenin signalling supports endocardial cushion expansion and cell proliferation during development, 14 indicate that sustained active Wnt/b-catenin signalling inhibits heart valve maturation after birth. Likewise, ECM compaction is not successfully achieved in Axin2 KO AoV indicating a potential link between Axin2/Wnt/b-catenin signalling and regulators of matrix compaction such as RhoGTPases. 27 Therefore, Axin2 and Wnt/b-catenin signalling regulate VIC proliferation and leaflet morphogenesis during postnatal heart valve maturation. 15 Altogether, our study suggests that Wnt/b-catenin signalling regulates ECM remodelling after birth and contributes to heart valve disease in adults.
Increased inflammatory cell infiltration precedes myxomatous valve disease in
Axin2 KO mice
Our study reveals that improper matrix composition and compaction at birth precedes heart valve dysfunction in adults. However, the process by which deficient leaflet remodelling after birth leads to myxomatous disease in adults is completely unknown. TGF-b and BMP signalling have been associated with MVD 2, 3 and are activated in VICs as observed in our Axin2 KO model. As TGF-b and BMP ligands are not increased in our model as opposed to human myxomatous mitral valves, 2,3 the increased phosphorylation of smad2/3 and smad1/5 could be due to of decreased expression of the inhibitory smad6. 28 Interestingly, thickening of heart valves has been reported in mice with smad6 loss of function 29 but its expression has not been reported yet in the context of myxomatous valve disease. Although TGF-b and BMP signalling pathways have been shown to modulate VECs, VICs and ECM in vitro, it has not yet been demonstrated that these pathways promote MVD in vivo. Our data suggest that TGF-b and BMP signalling activation occurs at later stages of disease when valve leaflets are already extensively remodelled. Thus, these pathways likely are activated in response to ECM abnormalities, functional changes, or inflammation. Therefore targeting TGF-b and BMP pathways might not be suitable to prevent the initial steps of MVD, but could slow down the progression of the disease.
Our analysis of Axin2 KO mice reveals for the first time that increased numbers of hematopoietic cells and macrophages precedes major myxomatous valvular changes evident at 4 months. Similarly, inflammation has been reported in MVD in humans 2 and mice 24 but the specific timing and contributions of inflammatory cells to disease progression have not been defined. The primary cause of increased inflammatory cells is still to be determined, but the absence of Axin2 expression in hematopoietic cells implies that increased inflammatory cell infiltration is the result of defective valve leaflet morphogenesis or ECM composition observed as early as P0 in Axin2 KO mice. Notably, ECM degradation and remodelling can influence immune cell infiltration and activation, as determined in studies of wound healing and fibrosis. 30 In addition, increased Wnt/b-catenin signalling in VICs can induce chemokine production which ultimately will attract macrophages. 31, 32 Since macrophages are major effectors in tissue remodelling and fibrosis, 33 our model is consistent with inflammation as a potential driver of MVD. However, future studies are needed to determine if inflammatory cells contribute to the pathogenesis of MVD or if anti-inflammatory therapy can prevent MVD during early stages of disease. In summary, this study reveals that Axin2 and inhibition of Wnt/b-catenin signalling contribute to proper heart valve maturation. Immature heart valves deficient in Axin2 exhibit progressive MVD during adulthood. Furthermore, increased inflammation precedes and potentially drives ECM remodelling as well as TGF-b and BMP signalling in MVD. Thus, the Axin2 KO mouse represents a novel murine model of myxomatous valve disease that will be useful for further studies of the progression of MVD and testing of potential therapeutic targets.
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